Joint Filing AgreementJoint Filing Agreement • February 14th, 2023 • Redmile Group, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the undersigned hereby agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto, the “Schedule 13G”) relating to the Common Stock of Zymeworks Inc., which may be deemed necessary pursuant to Regulation 13D or 13G promulgated under the Exchange Act.
